H-29892, Case Ascertainment for Epidemiologic Studies of Childhood Cancers and Hematological Conditions

Study ID
STU 042012-009

Cancer Related
Yes

Healthy Volunteers
Yes

Study Sites

  • Children's Medical Center-Dallas

Contact
Natasha Anderson
214-456-6439
natasha.anderson@childrens.com

Principal Investigator
Daniel Bowers

Summary

Texas Children's Cancer Center houses the epidemiology Center (epiCenter), which has developed the infrastructure to obtain questionnaire data from a large number of participants and to collect, process, and store biological samples for large epidemiological studies.
investigators in the epiCenter are well versed in the conduct of large epidemiological studies of childhood cancer. Therefore, the epiCenter will administer the epidemiological questionnaire for all subjects who are enrolled on this trial. at the time the questionnaire is administered, the subject's parents will be asked to donate a saliva sample for Dna extraction. We will then mail a saliva collection kit to the parents with instructions for collecting the sample and mailing it back to the epiCenter. epidemiological characteristics, Dna polymorphisms and levels of plasma proteins that are direct or indirect markers of environmental, dietary and infectious exposures, and encoded by the polymorphic genes in xenobiotic detoxification, Dna repair, apoptosis, inflammation and cell cycle pathways will be compared between pediatric cancer patients and healthy controls or among the families of the cases. a suitable set of population-based controls will be recruited under a separate protocol using either pediatric clinics in the relevant areas of Texas and oklahoma or the corresponding birth certificate registries. Both sources of controls have their pros and cons; this decision will be made by the study group with input from other epidemiologists with expertise in conducting large population-based casecontrol studies of childhood diseases. The laboratory assays will be guided by a priori hypotheses and by the epidemiological questionnaire. if the questionnaire suggests there is a difference in infection prevalence then we will focus on biological markers related to infections/inflammation (inflammation/cytokine levels, cytokine polymorphism comparisons). if the questionnaire suggests that there is a dietary difference in vitamin (e.g. folic acid) intake, then we would focus on biological markers related to that vitamin (folate serum level, folate polymorphism comparisons).

Participant Eligibility

1. Diagnosis of a childhood cancer or hematological condition
2. Age 18 years or younger at diagnosis

Inclusion Criteria for Control group:
1. Any infant/child/adolescent younger than 18 years of age who is not diagnosed or treated for cancer or hematological condition
OR
2. Any ll healthy siblings of children and adolescents diagnosed with cancer or hematological condition under the age of 18 years.